pediapharm Chef de file pharmaceutique en pédiatrie au Canada

Canada's Leading Pediatric Pharmaceutical Company

What's new

Pediapharm Announces the Extension of the Exclusive Canadian Rights for NYDA Until 2021, With a Clause for Additional 5 Year Renewals

Read more >

Pediapharm Inc. to Present at 2015 Bloom Burton & Co. Healthcare Investor Conference

Read more >

Pediapharm Inc. Announces Completion of Private Placement of Senior Secured Convertible Debentures and Warrants

Read more >


Stock – PDP.V